Investigators from Nanyang Technological University Zero in on Cancer Vaccines (Metal-organic Framework-based Nanovaccine for Relieving Immunosuppressive Tumors Via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis ...)

Press/Media

Period14 Jun 2024

Media coverage

1

Media coverage

  • TitleInvestigators from Nanyang Technological University Zero in on Cancer Vaccines (Metal-organic Framework-based Nanovaccine for Relieving Immunosuppressive Tumors Via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis ...)
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date14/06/24
    PersonsJINGJING GUO